Evoke Pharma
EVOK
$0.45
Share price
2.27%
Change (1 day)
-76.68%
Change (1 year)
Categories
Evoke Pharma (EVOK) - P/B ratio
P/B ratio as of May 2024 : -1.48
According to Evoke Pharma
's latest financial reports the company has a price-to-book ratio of -1.48.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Evoke Pharma - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -1.36 | -162.06% |
| 2022-12-31 | 2.19 | -56.58% |
| 2021-12-31 | 5.05 | -123.85% |
| 2020-12-31 | -21.2 | -334.42% |
| 2019-12-31 | 9.04 | -15.85% |
| 2018-12-31 | 10.7 | -33.25% |
| 2017-12-31 | 16.1 | 144.2% |
| 2016-12-31 | 6.59 | -3.97% |
| 2015-12-31 | 6.86 | 74.77% |
| 2014-12-31 | 3.92 | 83.03% |
| 2013-12-31 | 2.14 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | 3.03 | -304.61% | 🇺🇸 USA |
 Amphastar Pharmaceuticals AMPH | 3.15 | -313.15% | 🇺🇸 USA |
 Ironwood Pharmaceuticals
IRWD | -3.56 | 140.54% | 🇺🇸 USA |